ClinicalTrials.Veeva

Menu

A Micro/Nano Device for Exhaled Breath Analysis

University of Louisville (UOFL) logo

University of Louisville (UOFL)

Status

Completed

Conditions

Pulmonary Disease
Lung Cancer

Study type

Observational

Funder types

Other

Identifiers

NCT02123030
10.0642

Details and patient eligibility

About

Use of a microfabricated silicon device to concentrate ultra trace volatile organic compounds (VOCs) in human exhaled breath for quantitative analysis of VOCs.

Full description

Will use Fourier Transform Mass Spectrometry (FT-MS) and Gas Chromatography-Mass Spectrometry (GC-MS) to analyze concentrated VOCs. The purpose of this study is to search for disease-related markers in the breath in subjects with known or suspected lung or other cancer, or pulmonary disease.

Enrollment

728 patients

Sex

All

Ages

20 to 85 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • For controlled (healthy) subjects - we are seeking persons who do not have a known history of cancer or pulmonary disease.
  • Both smokers and nonsmokers are invited to participate as control subjects.
  • For experimental subjects, we are seeking persons with pulmonary disease but no known history of cancer, as identified by the investigators during routine clinic or office visits.
  • Additionally for experimental subjects, we are seeking persons with known or suspected lung or other cancers, as identified by the investigators during routine clinic or office visits.

Exclusion Criteria:

Trial design

728 participants in 2 patient groups

Experimental
Description:
patients with pulmonary disease; and, patients with known or suspected lung or other cancers
Control
Description:
healthy subjects (for example, family members of the patient or graduate students

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems